EYETECH PHARMACEUTICALS INC·5

Feb 11, 6:27 PM ET

EYETECH PHARMACEUTICALS INC 5

5 · EYETECH PHARMACEUTICALS INC · Filed Feb 11, 2005

Insider Transaction Report

Form 5
Period: 2004-12-31
ADAMIS ANTHONY P
Chief Scientific Officer
Transactions
  • Award

    Common Stock

    2004-07-30$17.85/sh+595$10,62119,919 total
Holdings
  • Common Stock

    (indirect: by Daughter)
    6,280
Footnotes (3)
  • [F1]Shares acquired under the EYET employee stock purchase plan on July 30, 2004.
  • [F2]These shares are held in a trust for the benefit of the reporting person's daughter. The reporting person's brother-in law is the trustee of the trust. The reporting person disclaims benefical ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for puposes of Section 16 or for any other purpose.
  • [F3]These shares are held in a trust for the benefit of the reporting person's son. The reporting person's brother -in-law is the trustee of the trust. The reporting person disclaims beneficial ownership of these securiites, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for Section 16 or for any other pupose.

Documents

1 file
  • 5
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT